Quick Answer
TELA Bio, Inc. reported Total Revenue of $80.28 million for fiscal year 2025.
TELA Bio, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $80.28M | +15.8% |
| 2024 | $69.30M | +18.6% |
| 2023 | $58.45M | +41.1% |
| 2022 | $41.42M | +40.6% |
| 2021 | $29.46M | +61.8% |
| 2020 | $18.21M | +17.9% |
| 2019 | $15.45M | +86.7% |
| 2018 | $8.27M | +94.9% |
| 2017 | $4.25M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $20.69M | +9.1% | +2.4% |
| June 30, 2025 | $20.20M | +25.5% | +9.1% |
| March 31, 2025 | $18.52M | +11.5% | -2.3% |
| September 30, 2024 | $18.96M | +25.9% | +17.8% |
| June 30, 2024 | $16.09M | +11.0% | -3.1% |
| March 31, 2024 | $16.60M | +39.4% | +10.3% |
| September 30, 2023 | $15.05M | +34.9% | +3.8% |
| June 30, 2023 | $14.49M | +39.3% | +21.7% |
- TELA Bio, Inc. showed an increase of +15.8% in Total Revenue compared to the prior fiscal year.
- Over the 2017–2025 period, TELA Bio, Inc.’s total revenue has grown by 1791.0% (from $4.25 million to $80.28 million).
- The most recent figure is from TELA Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: